Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (bilateral)
ICD-10 E09.3543 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (bilateral).
E09.3543 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to significant complications including proliferative diabetic retinopathy. This condition is characterized by the growth of abnormal blood vessels in the retina, which can lead to vision loss. In this specific case, the patient experiences both traction retinal detachment and rhegmatogenous retinal detachment in both eyes. Traction retinal detachment occurs when scar tissue pulls the retina away from the underlying tissue, while rhegmatogenous retinal detachment is caused by a tear or break in the retina. The combination of these two types of detachment poses a serious risk to vision and requires immediate medical intervention. Management of this condition often involves careful monitoring of blood glucose levels, typically assessed through HbA1c levels, and may necessitate insulin therapy or other medications to control diabetes. The complexity of this diagnosis lies in the multifactorial nature of the condition, requiring a comprehensive approach to treatment and coding.
Detailed retinal examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, diabetic retinopathy screenings, and surgical interventions for retinal detachment.
Ensure clear documentation of the type and severity of retinal detachment and any surgical procedures performed.
Comprehensive diabetes management records, including medication lists, HbA1c levels, and patient education notes.
Management of drug-induced diabetes, insulin therapy adjustments, and monitoring for complications.
Document the specific drugs causing diabetes and their impact on the patient's overall health.
Used for treating proliferative diabetic retinopathy.
Document the extent of retinopathy and treatment rationale.
Ophthalmology should provide detailed notes on the procedure and patient response.
HbA1c levels provide insight into the patient's long-term glycemic control, which is crucial for managing diabetes and preventing complications like retinopathy.
Drug-induced diabetes is specifically caused by medications or chemicals, unlike Type 1 or Type 2 diabetes, which have different etiologies and management strategies.
